D. Litvinavičiūtė holds a Master’s degree in Biochemistry from Vilnius University, Lithuania. She joined the Experimentica team in 2021 as a Senior Scientist, responsible for R&D project development and the expansion of molecular biology laboratories and services. In 2022, she assumed leadership of the histology laboratory and personnel as Head of Histology and Molecular Biology. In May 2025, she was appointed Associate Director of Molecular Biology and Histology at Experimentica’s Vilnius site in Lithuania.
Dr. Lelytė holds a Ph.D. degree in Biomedical Sciences from the University of Birmingham, UK. She joined the Experimentica team in 2018 as a scientist, gaining experience in preclinical in vivo studies modeling a range of ocular diseases. In May 2025, she was appointed as an Associate Director of In Vivo Pharmacology at Experimentica’s Vilnius site in Lithuania.
Dr. Artem Shatillo has a multidisciplinary background, holding a Medical Doctor degree in Psychiatry (2005), software development training (2006), and doctoral training in Imaging and Neurobiology from the University of Eastern Finland (2009-2015).
Dr. Kalesnykas earned his Ph.D. in Neuroscience in 2005 from the University of Kuopio and completed several postdoctoral fellowships studying the pathophysiology of glaucoma and ocular gene therapy. He currently serves as an Adjunct Professor of Experimental Ophthalmology at University of Tampere, Finland.
Dr. Vähätupa holds a Ph.D. degree in Biomedicine from Tampere University, Finland. She joined Experimentica Ltd. as a project researcher in angiogenesis-related studies in 2015. In 2019, Dr. Vähätupa took a role of in vivo team project coordinator and senior scientist. In September 2020, she was appointed as Director of In Vivo Pharmacology at Kuopio site, Finland.
Dr. Ragauskas holds a Ph.D. degree in Biology from Vytautas Magnus University, Lithuania. He joined the Experimentica team as a project researcher in 2013, where he gained experience in conducting in vivo preclinical studies for a large number of disease indications. In 2018, Dr. Ragauskas was appointed as Director of In Vivo Pharmacology at Experimentica UAB, Lithuania.
All our facilities are AAALAC accredited, reflecting our commitment to the highest standards of animal care in research.
Copyright: Experimentica Ltd. 2025
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
